Patent · US Active

Chemically modified oligonucleotides

US8017763B2 · kind B2 · utility

23Cited by

5References

27Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Muthiah Manoharan · Carlsbad, US
Venkitasamy Kesavan · Woburn, US
Kallanthottathil G. Rajeev · Wayland, US

Key dates

Filing date	Sep 17, 2009
Grant date	Sep 13, 2011
Priority date	—
Expiry date	Sep 17, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/51
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.